PB 100 of 2021
National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2021 (No. 9)
I, NIKOLAI TSYGANOV, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, and delegate of the Minister for Health and Aged Care, make the following determination.
Dated 28 September 2021
NIKOLAI TSYGANOV
Assistant Secretary (Acting)
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
Contents
1 Name…………………………………………………………………………….………………1
2 Commencement
3 Authority
4 Schedule
Schedule 1—Amendments 2
National Health (Continued Dispensing - Emergency Measures) Determination 2020 2
1 Name
(1) This instrument is the National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2021 (No. 9).
(2) This instrument may also be cited as PB 100 of 2021.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information |
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 October 2021 | 1 October 2021 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under subsection 89A(3) of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Continued Dispensing – Emergency Measures) Determination 2020
[1] Schedule 1, after entry for Brivaracetam in the form Tablet 75 mg
insert:
Brolucizumab | Solution for intravitreal injection 19.8 mg in 0.165 mL pre-filled syringe | Injection |
[2] Schedule 1, after entry for Ciclosporin in the form Capsule 50 mg
insert:
| Eye drops 1 mg per mL, single dose units 0.3 mL, 30 | Application to the eye |
[3] Schedule 1, omit entry for Nedocromil
[4] Schedule 1, omit entry for Nilutamide
[5] Schedule 1, entry for Nitrofurantoin
substitute:
Nitrofurantoin | Capsule 50 mg | Oral |
| Capsule 50 mg, USP | Oral |
| Capsule 100 mg | Oral |
[6] Schedule 1, after entry for Ocriplasmin
insert:
Ofatumumab | Solution for injection 20 mg in 0.4 mL pre-filled pen | Injection |
[7] Schedule 1, omit entry for Rituximab
[8] Schedule 1, entry for Sertraline
substitute:
Sertraline | Tablet 50 mg (as hydrochloride) | Oral |
| Tablet 100 mg (as hydrochloride) | Oral |
[9] Schedule 1, entry for Sunitinib
substitute:
Sunitinib | Capsule 12.5 mg | Oral |
| Capsule 25 mg | Oral |
| Capsule 37.5 mg | Oral |
| Capsule 50 mg | Oral |
[10] Schedule 1, entry for Terbutaline
omit:
| Powder for oral inhalation in breath actuated device containing terbutaline sulfate 500 micrograms per dose, 100 doses | Inhalation by mouth |
[11] Schedule 1, entry for Teriparatide
insert as first entry:
| Injection 250 micrograms per mL, 2.4 mL in multi-dose pre-filled cartridge | Injection |